×
About 2,299 results

ALLMedicine™ Troponins Center

Research & Reviews  1,081 results

Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppres...
https://doi.org/10.1159/000515675
Blood Purification; Mancianti N, Maresca B et. al.

Apr 28th, 2021 - Cardiovascular events (CVE) remain the leading cause of mortality in hemodialysis (HD) patients. The ability to assess the risk of short-term CVE is of great importance. Soluble suppression of tumorogenicity-2 (sST2) is a novel biomarker that bett...

The prognostic role of cardiac troponin in hospitalized COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052510
Atherosclerosis Tanboğa IH, Canpolat U et. al.

Apr 28th, 2021 - Myocardial injury defined by elevation of cardiac troponins (cTn) in the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though not fully characterized yet. Using the Turkish nationwide centralized COVID-19 database, we s...

Circulating Biomarkers for Cardiotoxicity Risk Prediction.
https://doi.org/10.1007/s11864-021-00845-0 10.3322/caac.21590 10.3322/caac.21565 10.1093/eurheartj/ehz766 10.1200/JCO.2002.20.5.1215 10.1016/j.annonc.2019.10.023 10.1016/j.echo.2014.07.012 10.1056/NEJMoa052306 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K 10.1056/NEJM199809243391307 10.1038/nm.2919 10.1016/j.jacc.2014.06.1167 10.1200/JCO.2005.05.827 10.1002/cncr.11407 10.1093/cvr/cvx183 10.1016/S0735-1097(00)00748-8 10.1093/annonc/mdf170 10.1161/CIRCULATIONAHA.106.635144 10.1200/JCO.2009.27.3615 10.1161/01.CIR.0000130926.51766.CC 10.1038/bjc.2011.439 10.1016/j.ijcard.2009.09.564 10.1007/s00277-003-0615-3 10.1007/s00392-007-0633-6 10.1161/JAHA.113.000403 10.1093/eurheartj/ehw172 10.1001/jama.2010.1768 10.1177/0004563216650464 10.1007/978-3-540-68964-5_15 10.1016/j.amjcard.2007.11.012 10.1093/eurheartj/ehw128 10.1161/CIRCHEARTFAILURE.112.968701 10.1161/CIRCULATIONAHA.115.017298 10.1373/clinchem.2005.050153 10.1371/journal.pone.0096736 10.1152/ajpheart.00252.2018 10.18632/oncotarget.14355 10.1200/JCO.2016.70.5400 10.1126/science.3798106 10.1056/NEJMoa0910383 10.1200/JCO.2011.40.0010 10.1136/esmoopen-2019-000659 10.1056/NEJMoa064320 10.1056/NEJMoa1113216 10.1016/j.amjcard.2011.01.006 10.1161/CIRCIMAGING.112.973321 10.1161/JAHA.119.014708 10.1634/theoncologist.2015-0321 10.1007/s10549-017-4628-3 10.1007/s13277-015-4183-7 10.1016/j.jacc.2013.10.061 10.1161/01.ATV.0000163262.83456.6d 10.1016/S1470-2045(18)30457-1 10.1007/s11886-017-0835-0 10.1007/s11936-019-0731-6 10.1016/S1470-2045(18)30608-9 10.1161/CIRCULATIONAHA.118.034497 10.1016/j.jacc.2018.02.037 10.1373/clinchem.2017.277186 10.1634/theoncologist.2019-0040 10.1634/theoncologist.2017-0452 10.1007/s11899-020-00567-4 10.1016/j.jacc.2019.10.038 10.1038/s41698-018-0056-z 10.1016/j.ctrv.2016.12.002 10.1016/j.jchf.2012.09.001 10.1158/1078-0432.CCR-16-2869 10.1002/ejhf.2017 10.1097/CRD.0000000000000183 10.1200/JCO.19.00231 10.1002/ajh.24176 10.1111/eci.12234 10.1002/ejhf.1920
Current Treatment Options in Oncology; Gong FF, Cascino GJ et. al.

Apr 18th, 2021 - Improvements in cancer survival have led to the emergence of cardiovascular disease as an important determinant of adverse outcome in survivors. Cancer therapeutics-related cardiac dysfunction is the most well-known form of cardiotoxicity. However...

Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Tech...
https://doi.org/10.1016/j.cpcardiol.2021.100818
Current Problems in Cardiology; Di Lisi D, Manno G et. al.

Mar 23rd, 2021 - In recent years, the cancer survival of patients has improved thanks to advances in the pharmacological field. In many guidelines, cardiotoxicity induced by anticancer drugs was defined as a reduction from baseline in the left ventricular ejection...

see more →

Clinicaltrials.gov  1,147 results

Serum Cardiac Biomarkers in Asymptomatic Hemodialysis Patients: Role of Soluble Suppres...
https://doi.org/10.1159/000515675
Blood Purification; Mancianti N, Maresca B et. al.

Apr 28th, 2021 - Cardiovascular events (CVE) remain the leading cause of mortality in hemodialysis (HD) patients. The ability to assess the risk of short-term CVE is of great importance. Soluble suppression of tumorogenicity-2 (sST2) is a novel biomarker that bett...

The prognostic role of cardiac troponin in hospitalized COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052510
Atherosclerosis Tanboğa IH, Canpolat U et. al.

Apr 28th, 2021 - Myocardial injury defined by elevation of cardiac troponins (cTn) in the course of coronavirus disease 2019 (COVID-19) pandemic has been reported, though not fully characterized yet. Using the Turkish nationwide centralized COVID-19 database, we s...

Hope, but No Home Runs: Biomarker Distinction Between MI Types
https://www.medscape.com/viewarticle/949770

Apr 21st, 2021 - Troponins, widely used to help confirm or rule out acute myocardial infarction (MI), aren't as helpful in separating different MI types. They aren't very reliable for discriminating between, for example, the atherothrombotic type (T1) MI and the o...

Circulating Biomarkers for Cardiotoxicity Risk Prediction.
https://doi.org/10.1007/s11864-021-00845-0 10.3322/caac.21590 10.3322/caac.21565 10.1093/eurheartj/ehz766 10.1200/JCO.2002.20.5.1215 10.1016/j.annonc.2019.10.023 10.1016/j.echo.2014.07.012 10.1056/NEJMoa052306 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K 10.1056/NEJM199809243391307 10.1038/nm.2919 10.1016/j.jacc.2014.06.1167 10.1200/JCO.2005.05.827 10.1002/cncr.11407 10.1093/cvr/cvx183 10.1016/S0735-1097(00)00748-8 10.1093/annonc/mdf170 10.1161/CIRCULATIONAHA.106.635144 10.1200/JCO.2009.27.3615 10.1161/01.CIR.0000130926.51766.CC 10.1038/bjc.2011.439 10.1016/j.ijcard.2009.09.564 10.1007/s00277-003-0615-3 10.1007/s00392-007-0633-6 10.1161/JAHA.113.000403 10.1093/eurheartj/ehw172 10.1001/jama.2010.1768 10.1177/0004563216650464 10.1007/978-3-540-68964-5_15 10.1016/j.amjcard.2007.11.012 10.1093/eurheartj/ehw128 10.1161/CIRCHEARTFAILURE.112.968701 10.1161/CIRCULATIONAHA.115.017298 10.1373/clinchem.2005.050153 10.1371/journal.pone.0096736 10.1152/ajpheart.00252.2018 10.18632/oncotarget.14355 10.1200/JCO.2016.70.5400 10.1126/science.3798106 10.1056/NEJMoa0910383 10.1200/JCO.2011.40.0010 10.1136/esmoopen-2019-000659 10.1056/NEJMoa064320 10.1056/NEJMoa1113216 10.1016/j.amjcard.2011.01.006 10.1161/CIRCIMAGING.112.973321 10.1161/JAHA.119.014708 10.1634/theoncologist.2015-0321 10.1007/s10549-017-4628-3 10.1007/s13277-015-4183-7 10.1016/j.jacc.2013.10.061 10.1161/01.ATV.0000163262.83456.6d 10.1016/S1470-2045(18)30457-1 10.1007/s11886-017-0835-0 10.1007/s11936-019-0731-6 10.1016/S1470-2045(18)30608-9 10.1161/CIRCULATIONAHA.118.034497 10.1016/j.jacc.2018.02.037 10.1373/clinchem.2017.277186 10.1634/theoncologist.2019-0040 10.1634/theoncologist.2017-0452 10.1007/s11899-020-00567-4 10.1016/j.jacc.2019.10.038 10.1038/s41698-018-0056-z 10.1016/j.ctrv.2016.12.002 10.1016/j.jchf.2012.09.001 10.1158/1078-0432.CCR-16-2869 10.1002/ejhf.2017 10.1097/CRD.0000000000000183 10.1200/JCO.19.00231 10.1002/ajh.24176 10.1111/eci.12234 10.1002/ejhf.1920
Current Treatment Options in Oncology; Gong FF, Cascino GJ et. al.

Apr 18th, 2021 - Improvements in cancer survival have led to the emergence of cardiovascular disease as an important determinant of adverse outcome in survivors. Cancer therapeutics-related cardiac dysfunction is the most well-known form of cardiotoxicity. However...

Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Tech...
https://doi.org/10.1016/j.cpcardiol.2021.100818
Current Problems in Cardiology; Di Lisi D, Manno G et. al.

Mar 23rd, 2021 - In recent years, the cancer survival of patients has improved thanks to advances in the pharmacological field. In many guidelines, cardiotoxicity induced by anticancer drugs was defined as a reduction from baseline in the left ventricular ejection...

see more →

News  71 results

Hope, but No Home Runs: Biomarker Distinction Between MI Types
https://www.medscape.com/viewarticle/949770

Apr 21st, 2021 - Troponins, widely used to help confirm or rule out acute myocardial infarction (MI), aren't as helpful in separating different MI types. They aren't very reliable for discriminating between, for example, the atherothrombotic type (T1) MI and the o...

Troponin, Echo a Prognostic Power Combo in COVID-19
https://www.medscape.com/viewarticle/939887

Oct 26th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The prevalence of troponin-defined myocardial injury exceeded 60% among selected patients hospitalized with COVID-19 at seven urban centers who un...

Heart Failure Biomarkers in COVID-19
https://www.staging.medscape.com/viewarticle/937938

Oct 20th, 2020 -   Muddy Water, Let Stand, Becomes Clear – Lao Tzu, 6th century With the pandemic spread of the SARS-CoV-2 virus and novel coronavirus disease 2019 (COVID-19), it has been widely observed that traditional biomarkers of heart failure such as cardiac...

Troponins Touted as 'Ally' in COVID-19 Triage, but Message Is Nuanced
https://www.staging.medscape.com/viewarticle/928614

Apr 12th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. Cardiac troponins by high-sensitivity assays (hs-cTn) should be considered "an ally and a crucial diagnostic and prognostic aid" during the COVID...

Troponins Touted as 'Ally' in COVID-19 Triage, but Message Is Nuanced
https://www.medscape.com/viewarticle/928614

Apr 12th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. Cardiac troponins by high-sensitivity assays (hs-cTn) should be considered "an ally and a crucial diagnostic and prognostic aid" during the COVID...

see more →